Artisan Partners’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.7M Sell
1,187,349
-333,351
-22% -$9.39M 0.05% 259
2025
Q4
$47.8M Buy
1,520,700
+155,601
+11% +$5.16M 0.07% 216
2025
Q3
$48.7M Buy
1,365,099
+378,844
+38% +$17.3M 0.07% 220
2025
Q2
$56.8M Buy
986,255
+46,796
+5% +$2.65M 0.08% 197
2025
Q1
$54.7M Buy
939,459
+513,742
+121% +$35.1M 0.09% 202
2024
Q4
$34.3M Sell
425,717
-24,712
-5% -$2.11M 0.05% 267
2024
Q3
$36.1M Sell
450,429
-26,805
-6% -$1.9M 0.05% 254
2024
Q2
$29.2M Buy
477,234
+123,421
+35% +$7.34M 0.04% 265
2024
Q1
$17.5M Sell
353,813
-16,824
-5% -$801K 0.03% 278
2023
Q4
$15.5M Buy
+370,637
New +$12.6M 0.02% 278

Other funds holding PRCT

Artisan Partners's PRCT Position: Q1 2026 in Review

Artisan Partners reduced its Procept Biorobotics (PRCT) stake by 22% in Q1 2026, selling an estimated $9.39M and leaving 1,187,349 shares worth $29.7M. The position accounts for 0.05% of the portfolio, ranked #259.

Artisan Partners first reported a position in PRCT in Q4 2023 and has held it in 10 quarters since. The position peaked at $56.8M in Q2 2025. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Artisan Partners held 1,187,349 shares of Procept Biorobotics worth $29.7M as of Q1 2026.
  • Artisan Partners sold 333,351 Procept Biorobotics shares in Q1 2026, an estimated $9.39M.
  • Procept Biorobotics made up 0.05% of Artisan Partners's portfolio in Q1 2026, its #259 holding.
  • Artisan Partners first reported a position in Procept Biorobotics in Q4 2023 and has held it in 10 quarters since.
  • Artisan Partners's Procept Biorobotics position peaked at $56.8M in Q2 2025.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Artisan Partners's 13F filing for Q1 2026, filed 13 May 2026.